ArticleFrontiers in epidemiology2026
Donor type dynamics and associated factors among blood donors in northern Ghana: a six-year retrospective analysis.
Article in Frontiers in epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Repeat blood donors have lower transfusion-transmissible infection (TTI) rates, making donor type distribution critical for blood safety. This study characterised donor type patterns, factors associated with first-time donation, and TTI prevalence differences in Northern Ghana. Methods: A retrospective cross-sectional analysis of 3,546 donor records (2017-2022) from seven health facilities in Upper West, Northern, and Oti regions. Donor type (first-time vs. repeat) was the primary outcome. Descriptive statistics, chi-square tests, and multivariable logistic regression were used. TTI prevalence, defined as positivity for at least one of HIV, HBV, HCV, or syphilis ("any TTI"), was compared between donor types. Significance was set at Results: First-time donors constituted 82.0% (2,907) and repeat donors 18.0% (639). Repeat donation increased from 12.3% (2020) to 22.6% (2022). Rural donors (93.1% first-time) and non-volunteer donors (82.5% first-time) showed higher proportions of first-time donation (both Conclusions: The predominance of first-time donors (82%) and low repeat donation rates represent a blood safety vulnerability that would benefit from targeted donor retention programs, particularly in rural areas and the Oti region.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.